134 related articles for article (PubMed ID: 34407176)
1. Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment.
Algora M; Mehmood T; Madison DL; AlAmeri J; Abuzakouk M; Tagamtam M; Acena L; Totaan G; Grabski G; Oumeziane N; Rajani P; Taylor L; Guzman J; AbdelWareth LO
Arch Pathol Lab Med; 2021 Dec; 145(12):1479-1484. PubMed ID: 34407176
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
[TBL] [Abstract][Full Text] [Related]
3. Screening donors for COVID-19 convalescent plasma.
Wang HE; Ostrosky-Zeichner L; Katz J; Wanger A; Bai Y; Sridhar S; Patel B
Transfusion; 2021 Apr; 61(4):1047-1052. PubMed ID: 33368395
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors.
Lasky B; Goodhue Meyer E; Steele WR; Crowder LA; Young PP
Transfusion; 2021 May; 61(5):1471-1478. PubMed ID: 33458811
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal analysis of SARS-CoV-2 antibodies in 8000 U.S. first-time convalescent plasma donations.
Karbiener M; Farcet MR; Ilk R; Schreiner J; Lenart J; Powers N; Stewart JM; Tallman H; Kreil TR
Transfusion; 2021 Apr; 61(4):1141-1147. PubMed ID: 33615484
[TBL] [Abstract][Full Text] [Related]
6. Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme-The South African Experience.
Glatt TN; Hilton C; Nyoni C; Swarts A; Swanevelder R; Cowley J; Mmenu C; Moyo-Gwete T; Moore PL; Kutama M; Jaza J; Phayane I; Brits T; Koekemoer J; Jentsch U; Nelson D; van den Berg K; Vermeulen M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696480
[TBL] [Abstract][Full Text] [Related]
7. Provision of COVID-19 Convalescent Plasma in a Resource-Constrained State.
Ipe TS; Le T; Quinn B; Kellar S; Clark M; Carlisle S; Rassmann A; Hennigan S; Ridenour T; Roberts A; Avery D; Ryan S; Pearson S; Kothari A; Patil N
Transfusion; 2020 Dec; 60(12):2828-2833. PubMed ID: 32989778
[TBL] [Abstract][Full Text] [Related]
8. How we secured a COVID-19 convalescent plasma procurement scheme in Japan.
Terada M; Kutsuna S; Togano T; Saito S; Kinoshita N; Shimanishi Y; Suzuki T; Miyazato Y; Inada M; Nakamoto T; Nomoto H; Ide S; Sato M; Maeda K; Matsunaga A; Satake M; Matsubayashi K; Tsuno H; Kojima M; Kuramistu M; Tezuka K; Ikebe E; Okuma K; Hamaguchi I; Shiratori K; Sato M; Kawakami Y; Inaba K; Igarashi S; Yamauchi R; Matsumura M; Ishimaru K; Zhang B; Kuge C; Ishihara M; Gouda M; Tanaka K; Ishizaka Y; Ohmagari N
Transfusion; 2021 Jul; 61(7):1998-2007. PubMed ID: 34096059
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area.
Jain S; Garg K; Tran SM; Rask IL; Tarczon M; Nandi V; Kessler DA; Strauss D; Sachais BS; Yazdanbakhsh K; Rehmani S; Luchsinger L; Shi PA
Transfusion; 2021 Aug; 61(8):2374-2383. PubMed ID: 33904609
[TBL] [Abstract][Full Text] [Related]
10. Deterrents in recruitment of COVID-19 convalescent plasma donors: Experience from a hospital-based blood centre in India.
Dhiman Y; Coshic P; Pandey HC; Khatiwada B; Singh J; Mehta V; Gupta S
Transfus Med; 2021 Jun; 31(3):149-154. PubMed ID: 33749020
[TBL] [Abstract][Full Text] [Related]
11. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.
Vandeberg P; Cruz M; Diez JM; Merritt WK; Santos B; Trukawinski S; Wellhouse A; Jose M; Willis T
Transfusion; 2021 Jun; 61(6):1705-1709. PubMed ID: 33715160
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda.
Muttamba W; Lusiba J; Namakula LO; Byakika-Kibwika P; Ssali F; Ddungu H; Mugenyi L; Kiwanuka N; Sekibira R; Kityo C; Keyune D; Acana S; Musinguzi A; Masasi A; Byamugisha J; Mpanju D; Musoki WJ; Tukamuhebwa HA; Nakwagala F; Bagaya BS; Kayongo A; Kimuli I; Nantanda R; Katagira W; Buregyeya E; Byanyima R; Byarugaba B; Siddharthan T; Mwebesa H; Charles O; Joloba ML; Bazeyo W; Kirenga B
PLoS One; 2021; 16(6):e0252306. PubMed ID: 34138909
[TBL] [Abstract][Full Text] [Related]
13. Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies.
De Silvestro G; Gandini G; Fiorin F; Marson P; Barbone E; Frigato A; Gessoni G; Veronesi A; Pacenti M; Castelli M; Rinaldi M; Rizzi M; Stefani F; Roveroni G
Transfus Apher Sci; 2021 Aug; 60(4):103154. PubMed ID: 33994107
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors.
Bansal N; Raturi M; Bansal Y
Transfus Clin Biol; 2021 Aug; 28(3):308-309. PubMed ID: 33971319
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216
[TBL] [Abstract][Full Text] [Related]
16. Detection of SARS-CoV-2-independent immunoregulatory activity of COVID-19 convalescent plasma.
Brox R; Achenbach S; Hackstein H
Transfusion; 2021 Nov; 61(11):3087-3093. PubMed ID: 34546583
[TBL] [Abstract][Full Text] [Related]
17. Rapid development of a de novo convalescent plasma program in response to a global pandemic: A large southeastern U.S. blood center's experience.
Reik R; Gammon RR; Carol N; Smith J; Grable M; Forbes S; Wu Y; Reed L; Rogers M; Prichard A; Paul S; Scholl G
J Clin Apher; 2021 Aug; 36(4):533-546. PubMed ID: 33648025
[TBL] [Abstract][Full Text] [Related]
18. A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors.
Drews SJ; Devine DV; McManus J; Mendoza E; Manguiat K; Wood H; Girardin R; Dupuis A; McDonough K; Drebot M
Transfusion; 2021 May; 61(5):1440-1446. PubMed ID: 33734448
[TBL] [Abstract][Full Text] [Related]
19. Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV-2 IgG antibodies compared to blood group A donations.
Hayes C; Rubenstein W; Gibb D; Klapper E; Tanaka J; Pepkowitz S
Transfusion; 2021 Aug; 61(8):2245-2249. PubMed ID: 34036595
[TBL] [Abstract][Full Text] [Related]
20. The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection.
Fazeli A; Sharifi S; Mohammadi S; Bahraini M; Arabkhazaeli A; Jelveh N; Eshghi P
Transfus Apher Sci; 2022 Apr; 61(2):103302. PubMed ID: 34774440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
